NCT02525016View on ClinicalTrials.gov

Safety Profile of IntRAvenous Lidocaine Use in Coelioscopic Bariatric Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

June 30, 2016

Conditions
ObesityBariatric Surgery
Interventions
BIOLOGICAL

Blood sampling

DRUG

Lidocaine

Trial Locations (1)

69437

Hôpital Edouard Herriot - Département d'anesthésie réanimation, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT02525016 - Safety Profile of IntRAvenous Lidocaine Use in Coelioscopic Bariatric Surgery | Biotech Hunter | Biotech Hunter